
Establishment Labs Holdings Inc. – NASDAQ:ESTA
Establishment Labs Holdings stock price today
Establishment Labs Holdings stock price monthly change
Establishment Labs Holdings stock price quarterly change
Establishment Labs Holdings stock price yearly change
Establishment Labs Holdings key metrics
Market Cap | 1.15B |
Enterprise value | 1.93B |
P/E | -22.78 |
EV/Sales | 11.99 |
EV/EBITDA | -33.51 |
Price/Sales | 11.30 |
Price/Book | -223.25 |
PEG ratio | 0.28 |
EPS | -3.14 |
Revenue | 155.79M |
EBITDA | -63.92M |
Income | -82.76M |
Revenue Q/Q | -20.11% |
Revenue Y/Y | -8.23% |
Profit margin | -46.51% |
Oper. margin | -24.53% |
Gross margin | 65.92% |
EBIT margin | -24.53% |
EBITDA margin | -41.03% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEstablishment Labs Holdings stock price history
Establishment Labs Holdings stock forecast
Establishment Labs Holdings financial statements
Jun 2023 | 48.56M | -16.74M | -34.48% |
---|---|---|---|
Sep 2023 | 38.50M | -29.27M | -76.02% |
Dec 2023 | 31.56M | -20.54M | -65.09% |
Mar 2024 | 37.16M | -16.20M | -43.59% |
Sep 2025 | 62.85M | -2.97M | -4.74% |
---|---|---|---|
Oct 2025 | 61.49M | -5.27M | -8.59% |
Dec 2025 | 69.65M | -2.08M | -2.99% |
Mar 2026 | 63.48M | -3.59M | -5.66% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 285299000 | 230.42M | 80.77% |
---|---|---|---|
Sep 2023 | 270533000 | 240.04M | 88.73% |
Dec 2023 | 268641000 | 250.24M | 93.15% |
Mar 2024 | 301838000 | 244.92M | 81.15% |
Jun 2023 | -28.24M | -9.04M | 84.49M |
---|---|---|---|
Sep 2023 | -31.51M | -6.6M | 487K |
Dec 2023 | -8.15M | -4.72M | -115.65K |
Mar 2024 | -11.15M | -6.62M | 51.04M |
Establishment Labs Holdings alternative data
Aug 2023 | 958 |
---|---|
Sep 2023 | 958 |
Oct 2023 | 958 |
Nov 2023 | 958 |
Dec 2023 | 958 |
Jan 2024 | 958 |
Feb 2024 | 958 |
Mar 2024 | 908 |
Apr 2024 | 908 |
May 2024 | 908 |
Jun 2024 | 908 |
Jul 2024 | 908 |
Establishment Labs Holdings other data
Period | Buy | Sel |
---|---|---|
Jul 2024 | 0 | 15000 |
Dec 2024 | 0 | 100000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | JW ASSET MANAGEMENT, LLC 10 percent owner | Common Shares | 100,000 | $45.15 | $4,515,000 | ||
Sale | CHACON QUIROS JUAN JOSE director, officer.. | Common Shares | 3,641 | $45.04 | $163,991 | ||
Sale | CHACON QUIROS JUAN JOSE director, officer.. | Common Shares | 654 | $45 | $29,431 | ||
Sale | CHACON QUIROS JUAN JOSE director, officer.. | Common Shares | 3,866 | $45.01 | $174,013 | ||
Sale | CHACON QUIROS JUAN JOSE director, officer.. | Common Shares | 6,839 | $45.3 | $309,773 | ||
Purchase | LEWIN NICHOLAS SHERIDAN director | Common Shares | 1,769 | $27.05 | $47,846 | ||
Purchase | LEWIN NICHOLAS SHERIDAN director | Common Shares | 231 | $26.96 | $6,227 | ||
Purchase | LEWIN NICHOLAS SHERIDAN director | Common Shares | 5,000 | $22 | $110,000 | ||
Purchase | DENHOY RAJ officer: Chief Financial Officer | Common Shares | 2,250 | $22.21 | $49,973 | ||
Option | LEWIN NICHOLAS SHERIDAN director | Common Shares | 250,000 | $18 | $4,500,000 |
Quarter | Transcript |
---|---|
Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Establishment Labs Holdings stock today?
One share of Establishment Labs Holdings stock can currently be purchased for approximately $37.37.
-
When is Establishment Labs Holdings's next earnings date?
Unfortunately, Establishment Labs Holdings's (ESTA) next earnings date is currently unknown.
-
Does Establishment Labs Holdings pay dividends?
No, Establishment Labs Holdings does not pay dividends.
-
How much money does Establishment Labs Holdings make?
Establishment Labs Holdings has a market capitalization of 1.15B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.13% to 165.15M US dollars.
-
What is Establishment Labs Holdings's stock symbol?
Establishment Labs Holdings Inc. is traded on the NASDAQ under the ticker symbol "ESTA".
-
What is Establishment Labs Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Establishment Labs Holdings?
Shares of Establishment Labs Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Establishment Labs Holdings's key executives?
Establishment Labs Holdings's management team includes the following people:
- Mr. Juan Jose Chacon Quiros Founder, Chief Executive Officer & Executive Director(age: 53, pay: $598,160)
- Mr. Salvador Santos Dada Chief Operating Officer (Medical Leave of Absence)(age: 42, pay: $468,620)
-
Is Establishment Labs Holdings founder-led company?
Yes, Establishment Labs Holdings is a company led by its founder Mr. Juan Jose Chacon Quiros.
-
How many employees does Establishment Labs Holdings have?
As Jul 2024, Establishment Labs Holdings employs 908 workers.
-
When Establishment Labs Holdings went public?
Establishment Labs Holdings Inc. is publicly traded company for more then 7 years since IPO on 19 Jul 2018.
-
What is Establishment Labs Holdings's official website?
The official website for Establishment Labs Holdings is establishmentlabs.com.
-
How can i contact Establishment Labs Holdings?
Establishment Labs Holdings can be reached via phone at +506 2434 2400.
Establishment Labs Holdings company profile:

Establishment Labs Holdings Inc.
establishmentlabs.comNASDAQ
908
Medical - Devices
Healthcare
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Alajuela,
CIK: 0001688757
ISIN: VGG312491084
CUSIP: G31249108